Long-acting (basal) insulin on Humana Premier Rx Plan (S5884-149)
Lantus, Basaglar, Tresiba and the other basal insulins, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Connecticut + 3 more
- Premium
- $138.60/month
- Deductible
- None
3 of 7 Long-acting insulin are covered on this plan. None require prior authorization.
4 aren't on the formulary, including insulin glargine and Basaglar.
- $45.00Tier 3
- $45.00Tier 3
- $45.00Tier 3
Not on the formulary
insulin glargine, Basaglar, Semglee, Rezvoglar
Patient cost for a 30-day supply at a preferred retail pharmacy. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.